Connect AccountAll persons or entities that purchased or otherwise acquired the common stock or 2% Convertible Senior Notes of Impax Laboratories, Inc. (now known as Impax Laboratories, LLC) (“Impax” or the “Company”) from February 20, 2014 through August 9, 2016, inclusive.
Final Approval
February 19, 2014 - November 04, 2016
March 31, 2022
March 04, 2022
JND Legal Administration
Impax Securities Settlement
c/o JND Legal Administration
PO Box 91417 Seattle, WA 98111
+1 833-823-0051
info@Impaxsecuritiessettlement.com
Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.